| 000 | 00995 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514223916.0 | ||
| 264 | 0 | _c20060413 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543784.14.3.343 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlebl, Bert M | |
| 245 | 0 | 0 |
_aAdvances in anti-viral therapeutics. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cMar 2005 |
||
| 300 |
_a343-8 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xchemistry |
| 650 | 0 | 4 |
_aDrugs, Investigational _xchemistry |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLondon |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xtrends |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 14 _gno. 3 _gp. 343-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.14.3.343 _zAvailable from publisher's website |
| 999 |
_c15501503 _d15501503 |
||